Cheng SS - Search Results

1

Time-Resolved Luminescent High-Throughput Screening Platform for Lysosomotropic Compounds in Living Cells.

Wu KJ, Wu C, Chen F, Cheng SS, Ma DL, Leung CH. Wu KJ, et al. Among authors: cheng ss. ACS Sens. 2021 Jan 22;6(1):166-174. doi: 10.1021/acssensors.0c02046. Epub 2020 Dec 28. ACS Sens. 2021. PMID: 33356166

2

Development of Natural Product-Conjugated Metal Complexes as Cancer Therapies.

Ma DL, Wu C, Cheng SS, Lee FW, Han QB, Leung CH. Ma DL, et al. Among authors: cheng ss. Int J Mol Sci. 2019 Jan 15;20(2):341. doi: 10.3390/ijms20020341. Int J Mol Sci. 2019. PMID: 30650627 Free PMC article. Review.

3

The design and development of covalent protein-protein interaction inhibitors for cancer treatment.

Cheng SS, Yang GJ, Wang W, Leung CH, Ma DL. Cheng SS, et al. J Hematol Oncol. 2020 Mar 30;13(1):26. doi: 10.1186/s13045-020-00850-0. J Hematol Oncol. 2020. PMID: 32228680 Free PMC article. Review.

4

Correction to: The design and development of covalent protein-protein interaction inhibitors for cancer treatment.

Cheng SS, Yang GJ, Wang W, Leung CH, Ma DL. Cheng SS, et al. J Hematol Oncol. 2020 Jul 24;13(1):102. doi: 10.1186/s13045-020-00938-7. J Hematol Oncol. 2020. PMID: 32709244 Free PMC article.

5

A Long-Lived Phosphorescence Amplification System Integrated with Graphene Oxide and a Stable Split G-Quadruplex Protector as an Isothermal "Off-On" Biosensor for the HBV Gene.

Ko CN, Cheng S, Leung CH, Ma DL. Ko CN, et al. ACS Appl Bio Mater. 2020 Jul 20;3(7):4556-4565. doi: 10.1021/acsabm.0c00481. Epub 2020 Jun 23. ACS Appl Bio Mater. 2020. PMID: 35025454

6

Inhibition of the CDK9-cyclin T1 protein-protein interaction as a new approach against triple-negative breast cancer.

Cheng SS, Qu YQ, Wu J, Yang GJ, Liu H, Wang W, Huang Q, Chen F, Li G, Wong CY, Wong VKW, Ma DL, Leung CH. Cheng SS, et al. Acta Pharm Sin B. 2022 Mar;12(3):1390-1405. doi: 10.1016/j.apsb.2021.10.024. Epub 2021 Oct 30. Acta Pharm Sin B. 2022. PMID: 35530158 Free PMC article.

7

Discovery of a tetrahydroisoquinoline-based CDK9-cyclin T1 protein-protein interaction inhibitor as an anti-proliferative and anti-migration agent against triple-negative breast cancer cells.

Cheng S, Yang GJ, Wang W, Ma DL, Leung CH. Cheng S, et al. Genes Dis. 2021 Jul 10;9(6):1674-1688. doi: 10.1016/j.gendis.2021.06.005. eCollection 2022 Nov. Genes Dis. 2021. PMID: 36157485 Free PMC article.

8

Dehydroeburicoic Acid, a Dual Inhibitor against Oxidative Stress in Alcoholic Liver Disease.

Cheng S, Kuang Y, Li G, Wu J, Ko CN, Wang W, Ma DL, Ye M, Leung CH. Cheng S, et al. Pharmaceuticals (Basel). 2022 Dec 22;16(1):14. doi: 10.3390/ph16010014. Pharmaceuticals (Basel). 2022. PMID: 36678511 Free PMC article.

9

A Bioactive Benzimidazole-Cyclometalated Iridium(III) Complex as an Epigenetic Regulator through Effectively Interrupting the EED-EZH2 Interaction.

Cheng S, Li J, Song YQ, Jing S, Lan YX, Wang L, Chan DS, Wong CY, Sheng C, Wang W, Wang HD, Leung CH. Cheng S, et al. Small. 2025 Mar;21(12):e2405771. doi: 10.1002/smll.202405771. Epub 2025 Feb 19. Small. 2025. PMID: 39967436

10

Efficient Dark Current Suppression by Engineering PIET-Active Discrete Donor-Acceptor Architecture for High-Sensitivity Semiconductor Photodetectors.

Song TT, Wang PK, Chen L, Cheng SS, Wang MS, Hu WP. Song TT, et al. Among authors: cheng ss. Adv Mater. 2025 Oct 25:e15057. doi: 10.1002/adma.202515057. Online ahead of print. Adv Mater. 2025. PMID: 41137640

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

242 results

Search Page

Filters